Archivos españoles de urología
-
To report a new case of penile incarceration by a metallic object. ⋯ Incarceration of the penis by a metallic object is an unusual clinical situation causing a vascular emergency and an incredible therapeutic challenge to remove the constructive object.
-
Comparative Study Clinical Trial
[Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].
Anemia is a frequent finding in patients with prostate cancer. Reduction of erythropoiesis caused by androgenic blockade is among its etiologies. Therefore, quality of life of these patients results decreased, being origin of significant morbidity and mortality. Recombinant forms of human erythropoietin have demonstrated their effectiveness improving quality of life of patients with various solid tumors, but specific studies in prostate cancer are a few. Our objective is to evaluate the efficacy of human recombinant erythropoietin (EPO) correcting anemia and improving the quality of life of patients with prostate cancer. ⋯ We consider that the administration of EPO increases significantly the levels of haemoglobin and the quality of life of patients with prostate adenocarcinoma, being the response worse in patients with low levels of baseline haemoglobin.
-
Rupture of the corpora cavernosum is an uncommon pathology requiring immediate treatment. We performed a bibliographic search, and analyzed different diagnostic and therapeutic methods. ⋯ Penile fracture is an uncommon pathology. Generally, history and physical examination are enough to establish the diagnosis. Penile ultrasound can help in case of doubt. Most urologists deem immediate surgery the standard therapy.
-
Tumors of the spermatic cord and epididymis are rare, and their exact incidence is difficult to determine. Ninety percent of extra testicular tumors within the scrotum are found in the spermatic cord, where 30% is malignant (1). ⋯ MO should be considered in the differential diagnosis of the spermatic cord tumors.
-
The Framework Program for Research and Technological Development constitutes the main instrument the European Union has had for financing research since 1984. The current Sixth Framework Program (6FP), that covers the period 2002-2006, includes clinical research among the activities subsidized at the European level. Other research activities in the field of medicine, particularly genomics and research activities connecting basic knowledge generation with its applications in the field of health also receive a special emphasis. ⋯ Both these and the more modest traditional instruments require participation of groups from different countries in a consortium, mainly from the European Community countries. The process of evaluation is carried out looking at relevance criteria, scientific excellence, potential impact, and quality of the consortium, among others. Spanish researchers, among others, are wellcome to participate in the consortiums, coordinate projects and also to assist as experts in the evaluations.